{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:12:38Z","timestamp":1789150358762,"version":"build-2803163510"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,2,9]]},"DOI":"10.7759\/cureus.34798","type":"journal-article","created":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T13:43:21Z","timestamp":1675950201000},"source":"Crossref","is-referenced-by-count":4,"title":["Rituximab-Induced Immune Dysregulation Leading to Organizing Pneumonia, Bronchiectasis, and Pulmonary Fibrosis"],"prefix":"10.7759","author":[{"given":"Mohammed","family":"Ayyad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Azar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram","family":"Albandak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Sharabati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Al-Tawil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08076.x","article-title":"The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases","volume":"149","author":"Cooper N","year":"2010","unstructured":"Cooper N, Arnold DM. The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases. Br J Haematol. 2010, 149:3-13. 10.1111\/j.1365-2141.2010.08076.x","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00080209","article-title":"Rituximab-induced lung disease: a systematic literature review","volume":"35","author":"Liot\u00e9 H","year":"2010","unstructured":"Liot\u00e9 H, Liot\u00e9 F, S\u00e9roussi B, Mayaud C, Cadranel J. Rituximab-induced lung disease: a systematic literature review. Eur Respir J. 2010, 35:681-7. 10.1183\/09031936.00080209","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1258","article-title":"Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)","volume":"101","author":"Byrd JC","year":"2003","unstructured":"Byrd JC, Peterson BL, Morrison VA, et al.. Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712). Blood. 2003, 101:6-14. 10.1182\/blood-2002-04-1258","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500144615","article-title":"Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim","volume":"46","author":"Macartney C","year":"2005","unstructured":"Macartney C, Burke E, Elborn S, et al.. Bronchiolitis obliterans organizing pneumonia in a patient with non-Hodgkin's lymphoma following R-CHOP and pegylated filgrastim. Leuk Lymphoma. 2005, 46:1523-6. 10.1080\/10428190500144615","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hon.799","article-title":"Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma","volume":"24","author":"Biehn SE","year":"2006","unstructured":"Biehn SE, Kirk D, Rivera MP, Martinez AE, Khandani AH, Orlowski RZ. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma. Hematol Oncol. 2006, 24:234-7. 10.1002\/hon.799","journal-title":"Hematol Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.102.1_supplement.38s","article-title":"Pathologic aspects of bronchiolitis obliterans organizing pneumonia","volume":"102","author":"Colby TV","year":"1992","unstructured":"Colby TV. Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest. 1992, 102:38S-43S. 10.1378\/chest.102.1_supplement.38s","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis WD","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al.. An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013, 188:733-48. 10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10710","article-title":"T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors","volume":"92","author":"Ditschkowski M","year":"2007","unstructured":"Ditschkowski M, Elmaagacli AH, Trenschel R, Peceny R, Koldehoff M, Schulte C, Beelen DW. T-cell depletion prevents from bronchiolitis obliterans and bronchiolitis obliterans with organizing pneumonia after allogeneic hematopoietic stem cell transplantation with related donors. Haematologica. 2007, 92:558-61. 10.3324\/haematol.10710","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-010-1447-8","article-title":"Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease","volume":"25","author":"Bitzan M","year":"2010","unstructured":"Bitzan M, Ouahed JD, Carpineta L, Bernard C, Bell LE. Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease. Pediatr Nephrol. 2010, 25:1163-7. 10.1007\/s00467-010-1447-8","journal-title":"Pediatr Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1378\/chest.96.5.967","article-title":"The concept of \"organizing pneumonia\"","volume":"96","author":"Sulavik SB","year":"1989","unstructured":"Sulavik SB. The concept of \"organizing pneumonia\". Chest. 1989, 96:967-9. 10.1378\/chest.96.5.967","journal-title":"Chest"},{"key":"ref11","article-title":"Cryptogenic Organizing Pneumonia","author":"Chandra D","year":"2022","unstructured":"Chandra D, Maini R, Hershberger DM. Cryptogenic Organizing Pneumonia. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-018-0121-y","article-title":"Pathophysiology and genetics of bronchiectasis unrelated to cystic fibrosis","volume":"196","author":"Nikolic A","year":"2018","unstructured":"Nikolic A. Pathophysiology and genetics of bronchiectasis unrelated to cystic fibrosis. Lung. 2018, 196:383-92. 10.1007\/s00408-018-0121-y","journal-title":"Lung"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0809","article-title":"Bronchiectasis--diagnosis and treatment","volume":"108","author":"Rademacher J","year":"2011","unstructured":"Rademacher J, Welte T. Bronchiectasis--diagnosis and treatment. Dtsch Arztebl Int. 2011, 108:809-15. 10.3238\/arztebl.2011.0809","journal-title":"Dtsch Arztebl Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0970-2113.142138","article-title":"Common variable immunodeficiency disorder - an uncommon cause for bronchiectasis","volume":"31","author":"Panigrahi MK","year":"2014","unstructured":"Panigrahi MK. Common variable immunodeficiency disorder - an uncommon cause for bronchiectasis. Lung India. 2014, 31:394-6. 10.4103\/0970-2113.142138","journal-title":"Lung India"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03166.x","article-title":"Complement activation plays a key role in the side-effects of rituximab treatment","volume":"115","author":"van der Kolk LE","year":"2001","unstructured":"van der Kolk LE, Grillo-L\u00f3pez AJ, Baars JW, Hack CE, van Oers MH. Complement activation plays a key role in the side-effects of rituximab treatment. Br J Haematol. 2001, 115:807-11. 10.1046\/j.1365-2141.2001.03166.x","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.949","article-title":"Rituximab-induced acute pulmonary fibrosis","volume":"79","author":"Leon RJ","year":"2004","unstructured":"Leon RJ, Gonsalvo A, Salas R, Hidalgo NC. Rituximab-induced acute pulmonary fibrosis. Mayo Clin Proc. 2004, 79:949. 10.4065\/79.7.949","journal-title":"Mayo Clin Proc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/136013-rituximab-induced-immune-dysregulation-leading-to-organizing-pneumonia-bronchiectasis-and-pulmonary-fibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:09Z","timestamp":1707508689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/136013-rituximab-induced-immune-dysregulation-leading-to-organizing-pneumonia-bronchiectasis-and-pulmonary-fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,9]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.34798","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,9]]}}}